NEWS
Singapore heavyweights in final sign-off for TPG’s Novotech
SINGAPORE: TPG Capital’s quest to secure a payday at its clinical trials business Novotech is… read more
Star biotech Telix in $1.2b revenue pledge
MELBOURNE: Telix Pharmaceuticals forecast revenue of up to $1.23 billion in fiscal 2025 ahead of… read more
US pharma giant in $672m bid for Mayne
SYDNEY: Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid… read more
